Navigation Links
Concord Medical Completes its Twelfth Annual Academic Conference
Date:12/5/2011

BEIJING, Dec. 5, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited (the "Company" or "Concord Medical") (NYSE: CCM), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it hosted the Twelfth Annual CCM Academic Conference in Beijing on December 3 and 4, 2011.

During the conference, doctors and researchers shared their clinical and academic experience in several subdivisions of radiotherapy and diagnostic imaging. More than 300 medical experts participated in the conference, including representatives from the Chinese Society of Radiation Oncology, the Chinese Society of Nuclear Medicine, and distinguished radiation oncologists from overseas. Doctors and oncologists from each of Concord Medical's centers also participated in the conference.

Each year, the event is one of the largest oncology academic events held in China. The 2011 conference was the largest in Concord Medical's history, measured by both the number of participants and number of academic papers presented.

Professor Yexun Li, of the China Oncology Hospital and China Academy of Medical Sciences, who is also the President of the Chinese Society of Radiation Oncology, said, "The annual CCM Academic Conference has become the highlight event for the radiation oncology field in China, and is greatly helping to pave the way for the profession's further development. Our academic community has been very fortunate to collaborate with and receive support from Concord Medical Services."

"Humanity is the foundation. Academic excellence is our pursuit," added Dr. Jianyu Yang, Chairman of the Board and CEO of the Company. "The annual Concord Medical conference provides both a platform to share clinical practice and academic research and a bridge to enhance collaboration within our own network and with radiation
'/>"/>

SOURCE Concord Medical Services Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Study Shows Concord Grape Juice has a Heart-Healthy Effect not yet Reported With Red Wine
2. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
3. Concord Grape Juice Has No Significant Impact on Body Weight
4. Concord Medical to Report First Quarter 2010 Financial Results on Thursday, May 27, 2010
5. Concord Medical Announces New Centers Opening at Hospital Partner
6. Concord Medical Announces Share Repurchase Program
7. Concord Medical Files 2009 Annual Report on Form 20-F
8. Concord Medical Enters into Joint Venture Agreement with ChangAn Hospital
9. Concord Medical to Report Second Quarter 2010 Financial Results on Wednesday, August 18, 2010
10. Concord Medical Announces Second Quarter 2010 Financial Results
11. Concord Medical to Hold Annual General Meeting on December 11, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Endo International plc (NASDAQ: ... quarter 2014 revenues of $719 million, an increase of ... $712 million. Endo reported net income of $21 million ... of $35 million in the second quarter of 2013.  ... net income for the three months ended June 30, 2014 ...
(Date:7/31/2014)... Auxilium Pharmaceuticals, Inc. (NASDAQ: ... today announced that the Company will receive a ... Asahi Kasei Pharma Corporation (Asahi Kasei). The payment ... a regulatory application to the Japanese Pharmaceutical and ... (collagenase clostridium histolyticum) for the treatment of Dupuytren,s ...
(Date:7/30/2014)... Advanced Photonix ® (NYSE MKT: API) will ... results on Monday, August 11, 2014. A press release announcing ... the market and the Company will host a live audio ... on the same day. Participating in the call ... Rob Risser (COO and Director), and Jeff Anderson ...
Breaking Medicine Technology:Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5
... COLLEGEVILLE, Pa., and TARRYTOWN, N.Y., May 22 ... ), and Progenics,Pharmaceuticals, Inc. (Nasdaq: PGNX ), ... with investigational oral and,intravenous formulations of RELISTOR(TM) (methylnaltrexone ... phase 2 trial, evaluated the effects of,an oral ...
... LAS VEGAS, May 22 CardioVascular,BioTherapeutics, Inc. (OTC Bulletin ... Christopher Moore to be the sponsor and general,partner of ... of,$1 million and up to $10 million of the ... am extremely impressed with CVBT,s wound healing drug, which ...
Cached Medicine Technology:Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 2Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 3Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 4Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 5Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 6Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 7Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 2Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 3
(Date:7/31/2014)... (PRWEB) July 31, 2014 Web Programming ... ISO 9001:2008 certified internet marketing firm, has recently launched ... to make this service affordable for everyone, the company ... the service. , Web Programming Services has tailored ... world of brochure designing and likely expectations of the ...
(Date:7/31/2014)... -- Recovery time after surgery may be reduced for ... to a new study. The study,s Irish researchers ... response, reducing the amount of time surgical patients, wounds ... true among people who tend to have healing complications. ... prescribed medications in the world. While they are typically ...
(Date:7/31/2014)... July 31, 2014 Ethane Web ... has introduced a new service named ‘Java Development’. ... Web Technologies has designed the service after doing ... and Java Development service being provided by other ... a confidence to promise outstanding Java Development service. ...
(Date:7/31/2014)... a unique protein that has the unusual property of destroying ... therefore be continually recreated and is no stable protein. The ... of coagulated blood. If you get a blood clot, it ... accumulated in a blood vessel, and therefore PAI-1 is extremely ... for helping people with a blood clot or other blood ...
(Date:7/31/2014)... Healthinsurancefacts.org has released a new blog post ... comparing quotes. , In order to find affordable ... quotes. They can do this by visiting an insurance ... , Clients should do proper research when looking for ... and each of them can be advantageous in the ...
Breaking Medicine News(10 mins):Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2Health News:Cholesterol Drugs May Speed Healing After Surgery 2Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:Breakthrough in understanding of important blood protein 2Health News:Breakthrough in understanding of important blood protein 3Health News:Comparing Health Insurance Quotes Can Help Clients Find Affordable Plans 2
... Weight Control Centers in Baltimore ... ... MED ) today announced that Medifast Franchise Systems has sold its,first franchise ... four Medifast Weight Control Centers in the Greater,Baltimore Metropolitan Area., The ...
... ocean and coastal environment is intimately linked to our health. ... Our beaches and coastal waters are increasingly contaminated. Yet there ... natural products and seafood benefits our oceans hold. ... says NOAA,s Juli Trtanj who serves as head of the ...
... Old London(R) Challenges Americans to Get Fit and Live a Healthier ... Lifestyle in ... Food Company, is launching a multi-faceted campaign aimed at,helping women renew their commitment ... feeling women get when they,are able to fit into an old pair of ...
... Management Services Corporation,(ADAMS) announced today that they ... Hospitals in Cleveland, Ohio with a target,completion ... hundred million,dollars will allow University Hospitals to ... also allowing them to provide further,research capabilities ...
... cutting-edge research with renowned clinics to,care for North ... WORTH, Texas, Feb. 18 The University of,North ... The Center for,Cancer and Blood Disorders [ http://www.texascancercare.com/ ... and Blood Disorders. The new,Institute,s goal is to ...
... ST. PAUL, Minn., Feb. 18 Regions Hospital,this week ... a first of,its kind in the region -- with ... unit will work a seven-day-on/seven-day-off schedule,providing improved continuity and ... model involves psychiatrists who will provide care for,patients once ...
Cached Medicine News:Health News:Medifast Franchise Systems Sells First Territory in Baltimore 2Health News:Medifast Franchise Systems Sells First Territory in Baltimore 3Health News:Oceans, coasts and your health: Reducing risks and reaping rewards 2Health News:Old London Launches Skinny Jeans Contest 2Health News:Old London Launches Skinny Jeans Contest 3Health News:Old London Launches Skinny Jeans Contest 4Health News:ADAMS Performs Management Services for University Hospitals' $600 Million Expansion/Renovation Program in Cleveland, OH 2Health News:UNT Health Science Center and The Center for Cancer and Blood Disorders Collaborate on New Institute for Cancer and Blood Disorders 2Health News:UNT Health Science Center and The Center for Cancer and Blood Disorders Collaborate on New Institute for Cancer and Blood Disorders 3Health News:Regions Hospital to Open New Inpatient Behavioral Health Unit 2
The AGC Revision Knee, extends the AGC Family to include implants for severe primary knees or revision. Provides rotational freedom of +/- 2 and varus/valgus freedom of +/- 1.5....
The Performance Knee System is a wide and easy to use system that offers enough options to cover any indication for primary and revision knee surgery, and all this with extensive intraoperative flexi...
The NexGen CR femoral component is intended for patients who, in the physician's judgement, have good bone stock and whose ligaments provide adequate mediolateral, anteroposterior, and varus/valgus s...
Cruciate retaining, posterior stabilized and constrained components....
Medicine Products: